GSK, which has major operations in Philadelphia and Montgomery County, is making a change at the top. Join John George as he ...

British pharmaceutical giant GSK on Monday said longtime chief executive Emma Walmsley will be replaced by its chief ...

Emma Walmsley, who in 2017 became the first woman to lead a major pharmaceutical company, will step down from her post as CEO ...

GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the ...

GSK will invest $30 billion in U.S. R&D and manufacturing, including a new biologics factory, AI upgrades, and expanded drug ...

The multi-billion, multi-year investment comes as many of GSK’s pharma peers pull away from the U.K., either suspending or ...

GSK commits $30B to U.S. R&D and manufacturing, with advanced AI-driven biopharma facilities set to expand jobs and innovation.

GSK ( NYSE: GSK) said it is planning to invest at least $30B across the U.S. in research and development and supply chain ...

Drugmaker GSK said Wednesday it would invest $30 billion in U.S. research and development and supply chain infrastructure ...

In its statement, GSK said the $30 billion investment would include capital investments in its U.S. supply chain and more ...

The pharmaceutical company plans to break ground on a new manufacturing facility in Upper Merion, Pennsylvania, in 2026.

GSK names Luke Miels as next CEO, succeeding Emma Walmsley at a pivotal time as the drugmaker sets ambitious growth targets ...